Equity Details
Price & Market Data
Price: $1.82
Daily Change: -$0.08 / 4.40%
Daily Range: $1.66 - $2.06
Market Cap: $6,196,240
Daily Volume: 308,735
Performance Metrics
1 Week: 8.18%
1 Month: 18.62%
3 Months: -26.96%
6 Months: -85.88%
1 Year: -83.22%
YTD: -65.99%
About Co-Diagnostics, Inc. (CODX)
Get up-to-date information on Co-Diagnostics, Inc. (CODX). The stock is trading at 1.82, with a daily performance indicating a change of -$0.08 / 4.40%. Its market cap is recorded at 6,196,240. Delve into detailed performance metrics, from short-term (1-week) to long-term (1-year) and year-to-date returns.
Company Details
Employees: 115
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.